The cell game : Sam Waksal's fast money and false promises--and the fate of ImClone's cancer drug
(Book)
Author
Status
General Shelving - 3rd Floor
HD9675.A672 W35 2004
1 available
HD9675.A672 W35 2004
1 available
Description
Loading Description...
Also in this Series
Checking series information...
Copies
| Location | Call Number | Status |
|---|---|---|
| General Shelving - 3rd Floor | HD9675.A672 W35 2004 | On Shelf |
Subjects
LC Subjects
Antineoplastic agents industry -- Corrupt practices -- United States.
Biographies.
Businessmen -- United States -- Biography.
Cancer -- Chemotherapy.
Drugs -- United States -- Testing.
ImClone Systems Incorporated -- History.
Insider trading in securities -- United States.
Monoclonal antibodies -- Research -- United States -- History.
Waksal, Samuel David.
Biographies.
Businessmen -- United States -- Biography.
Cancer -- Chemotherapy.
Drugs -- United States -- Testing.
ImClone Systems Incorporated -- History.
Insider trading in securities -- United States.
Monoclonal antibodies -- Research -- United States -- History.
Waksal, Samuel David.
OCLC Fast Subjects
Other Subjects
Antibodies, Monoclonal -- economics
Anticorps monoclonaux -- Recherche -- États-Unis -- Histoire.
Antineoplastic Agents -- economics
Biographies.
Biography
Biotechnology -- economics
Cancer -- Chimiothérapie.
collective biographies.
Ethics, Business -- history
Hommes d'affaires -- États-Unis -- Biographies.
ImClone Systems Incorporated.
Médicaments -- États-Unis -- Essais cliniques.
Opérations d'initié (Valeurs mobilières) -- États-Unis.
United States
Waksal, Samuel David.
Anticorps monoclonaux -- Recherche -- États-Unis -- Histoire.
Antineoplastic Agents -- economics
Biographies.
Biography
Biotechnology -- economics
Cancer -- Chimiothérapie.
collective biographies.
Ethics, Business -- history
Hommes d'affaires -- États-Unis -- Biographies.
ImClone Systems Incorporated.
Médicaments -- États-Unis -- Essais cliniques.
Opérations d'initié (Valeurs mobilières) -- États-Unis.
United States
Waksal, Samuel David.
More Details
Format
Book
Physical Desc
xviii, 412 pages ; 24 cm
Language
English
Notes
Bibliography
Includes bibliographical references and index.
Description
A behind-the-scenes profile of biotech company ImClone profiles Sam Waksal as a charismatic opportunist who led cancer patients to believe that a breakthrough treatment was imminent, citing the contributions of key investors, researchers, and business affiliates.
Local note
SACFinal081324
Reviews from GoodReads
Loading GoodReads Reviews.
Citations
APA Citation, 7th Edition (style guide)
Prud'homme, A. (2004). The cell game: Sam Waksal's fast money and false promises--and the fate of ImClone's cancer drug . HarperBusiness.
Chicago / Turabian - Author Date Citation, 17th Edition (style guide)Prud'homme, Alex. 2004. The Cell Game: Sam Waksal's Fast Money and False Promises--and the Fate of ImClone's Cancer Drug. New York: HarperBusiness.
Chicago / Turabian - Humanities (Notes and Bibliography) Citation, 17th Edition (style guide)Prud'homme, Alex. The Cell Game: Sam Waksal's Fast Money and False Promises--and the Fate of ImClone's Cancer Drug New York: HarperBusiness, 2004.
Harvard Citation (style guide)Prud'homme, A. (2004). The cell game: sam waksal's fast money and false promises--and the fate of imclone's cancer drug. New York: HarperBusiness.
MLA Citation, 9th Edition (style guide)Prud'homme, Alex. The Cell Game: Sam Waksal's Fast Money and False Promises--and the Fate of ImClone's Cancer Drug HarperBusiness, 2004.
Note! Citations contain only title, author, edition, publisher, and year published. Citations should be used as a guideline and should be double checked for accuracy. Citation formats are based on standards as of August 2021.
Staff View
Loading Staff View.